Intellia Therapeutics, Inc. (NTLA) has 10 identified peers for comparison in the Healthcare sector. Peers include BEAM, CRBU, CRSP, DNA, EDIT, FATE and others.
NTLA has a market capitalization of $1.75B, compared to an average peer market cap of $12.52B. NTLA is notably smaller than its average peer.
